OPTITHERA confirms that the introduction of its multiPRS test is cost effective in the care of renal complications of patients with diabetes

March 1, 2021

Need more information about this research?

Read more

Contact us

Interested in learning more about the
OPTITHERA test?

Call us at 514-890-8247

or send us an email at
info@optithera.onmicrosoft.com

900 Saint-Denis Street, Suite R14.404
Montreal, Quebec, Canada  H2X 0A9

Alert me as soon as the Optithera test is available.

Abonnement - Anglais

Facebook-f Twitter
Copyright © Optithera 2025

Upcoming test

Polygenic risk score for cardiorenal risk in subjects with type-2 diabetes

Be informed